https://nsc119875chemical.com/....exploration-around-t
Persister cells is a leading cause of recalcitrant disease and antibiotic drug treatment failure, and there is no drug in clinical use that specifically targets persister cells currently. Right here, we report a promising combination therapy of salt new houttuyfonate (SNH) and berberine chloride (BBR) which can be in a position to eradicate both developing and persistent drug-resistant Staphylococcus aureus. at 512 μg/mL. MICs of BBR in conjunction with 1/2 MIC SNH decreased by 4 to 64 folds compa
Like
Comment
Share
